¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"dominant cystoid macular dystrophy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dominant receptor
    ¿ì¼º¼ö¿ëü
  • dominant trait
    ¿ì¼º¼ÒÁú
  • facioscapulohumeral muscular dystrophy
    ¾ó±¼¾î±úÀ§ÆÈ±ÙÀ°µð½ºÆ®·ÎÇÇ
  • Fuchs endothelial dystrophy
    Ç«½º³»ÇǼ¼Æ÷ÀÌ»óÁõ
  • granular corneal dystrophy
    °ú¸³°¢¸·ÀÌ»óÁõ
  • homozygous dominant
    µ¿Á¾Á¢Çտ켺-
  • incompletely dominant
    ºÒ¿ÏÀü¿ì¼º-
  • infantile neuroaxonal dystrophy
    ¿µ¾Æ½Å°æÃà»èµð½ºÆ®·ÎÇÇ
  • lattice corneal dystrophy
    °ÝÀÚ°¢¸·ÀÌ»óÁõ
  • limb-girdle muscular dystrophy
    ÆÈ´Ù¸®ÀÌÀ½±Ù(À°)µð½ºÆ®·ÎÇÇ, Áö´ë±Ùµð½ºÆ®·ÎÇÇ
  • muscular dystrophy
    ±Ù(À°)µð½ºÆ®·ÎÇÇ
  • myotonic dystrophy
    ±Ù(À°)±äÀåµð½ºÆ®·ÎÇÇ
  • median nail dystrophy
    Á¤Áß¼Õ¹ßÅéÀÌ»óÁõ
  • oculopharyngeal muscular dystrophy
    ´«ÀεαÙ(À°)µð½ºÆ®·ÎÇÇ
  • progressive muscular dystrophy
    ÁøÇà±Ù(À°)µð½ºÆ®·ÎÇÇ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dominant trait
    ¿ì¼º¼ÒÁú
  • homozygous dominant
    µ¿Á¾Á¢Çտ켺
  • sex-linked dominant inheritance
    ¼º¿¬°ü¿ì¼ºÀ¯Àü
  • adiposogenital dystrophy
    Áö¹æÁõ¼º±âÅðÇàÀ§Ãà
  • dystrophy
    ÅðÇàÀ§Ãà, ¿µ¾çÀå¾Ö, ÀÌ»óÁõ
  • dermo-chondro-corneal dystrophy
    ÇǺο¬°ñ°¢¸·ÀÌ»óÁõ
  • facioscapulohumeral muscular dystrophy
    ¾ó±¼¾î±úÀ§ÆÈ±ÙÀ°ÅðÇàÀ§Ãà
  • granular corneal dystrophy
    °ú¸³°¢¸·ÀÌ»óÁõ
  • infantile neuroaxonal dystrophy
    ¿µ¾Æ½Å°æÃà»èÅðÇàÀ§Ãà
  • lattice corneal dystrophy
    °ÝÀÚ°¢¸·ÀÌ»óÁõ
  • limb-girdle muscular dystrophy
    »çÁö¿¬°á±ÙÀ°ÅðÇàÀ§Ãà, ÆÈ´Ù¸®ÀÌÀ½±ÙÀ°ÅðÇàÀ§Ãà
  • median nail dystrophy
    Áß¾Ó¼Õ¹ßÅéÀÌ»óÁõ
  • metachromatic dystrophy
    ÀÌ¿°ÅðÇàÀ§Ãà
  • muscular dystrophy
    ±ÙÀ°ÅðÇàÀ§Ãà
  • myotonic dystrophy
    ±ÙÀ°±äÀåÅðÇàÀ§Ãà
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hereditary corneal dystrophy
    À¯Àü¼º°¢¸·ÀÌ¿µ¾çÁõ.
  • hereditary corneal dystrophy
    À¯Àü¼º °¢¸·ÀÌ ¿µ¾çÁõ.
  • infantile neuroaxonal dystrophy
    ¿µ¾Æ½Å°æÃà»è¼º ÀÌ¿µ¾çÁõ, »çÀÌÅйö°Å¾¾º´.
  • peroneal muscular dystrophy
    ºñ°ñ±ÙÀ§ÃàÁõ(Þ¡ÍéÐÆê×õêñø)
  • pigmentary retinal dystrophy
    »ö¼Ò¸Á¸·ÀÌ¿µ¾çÁõ, ¸Á¸·»ö¼Òº¯¼º
  • progressive muscle dystrophy
    ÁøÇ༺ ±ÙÀÌ¿µ¾çÁõ(òäú¼àõÐÉì¶ç½å×ñø).
  • progressive muscle dystrophy
    ÁøÇ༺ ±ÙÀÌ¿µ¾çÁõ(òäú¼àõ ì¶ç½å×ñø)
  • pseudohypertrophy,in muscular dystrophy
    ±ÙÀÌ¿µ¾ç(Áõ)ÀÇ ¡­(ÐÉì¶ç½å×(ñø)¡­)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dominant
    ¿ì¼ºÀÇ
  • dominant autosomal gene
    ¿ì¼ºº¸Åë¿°»öüÀ¯ÀüÀÚ
  • dominant character
    ¿ì¼ºÇüÁú(¡­û¡òõ), Áö¹èÀû Ư¼º(ò¨ÛÕîÜ÷åàõ).
  • dominant complement
    ¿ì¼ºº¸Ã¼(¡­ÜÍô÷).
  • dominant dystrophic epidermolysis bullosa
    ¿ì¼º ÀÌ¿µ¾ç¼º ¼öÆ÷¼º Ç¥Çǹڸ®Áõ
  • dominant exudative vitreoretinopathy
    ¿ì¼º»ïÃâÀ¯¸®Ã¼¸Á¸·º¯Áõ
  • dominant eye
    ¿ì¼¼¾È
  • dominant gene
    ¿ì¼ºÀ¯ÀüÀÚ
  • dominant gene
    ¿ì¼ºÀ¯ÀüÀÚ(¡­ë¶îîí­).
  • dominant gene
    ¿ì¼ºÀ¯ÀüÀÚ(éÐàõë¶îîí­).
  • dominant hemisphere
    Áö¹è ´ë³ú¹Ý±¸
  • dominant hemisphere
    ¿ì¼º´ë³ú¹Ý±¸(¡­ÓÞÒàÚâϹ).
  • dominant hemisphere
    ¿ì¼º´ë³ú¹Ý±¸(¡­ÓÞÒàÚãϹ).
  • dominant inheritance
    ¿ì¼ºÀ¯Àü(¡­ë¶îî).
  • dominant mutation
    ¿ì¼º[µ¹¿¬]º¯ÀÌ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CMD campomelic dysplasia; camptomelic dwarfism; cartilage matrix deficiency; chief medical director; chi...
LCD coal tar solution [liquor carbonis detergens]; lattice corneal dystrophy; liquid crystal diode; loca...
MD Doctor of Medicine [Lat. Medicinae Doctor]; magnesium deficiency; main duct; maintenance dose; major...
ARMD Age-Related Macular Degeneration; ³ëÀμº Ȳ¹Ý Çü¼º
CMD Cerebro-Macular Degeneration
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CSME Clinically significant macular edema
FTMH Full-thickness macular holes
MP Macular pigment
SMD Senile macular degeneration
AD Autosomal Dominant
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • macular change
    ¹ÝÁ¡¼º º¯È­
  • macular enanthema
    ¹ÝÁ¡¼º Á¡¸·Áø
  • macular fixation
    Ȳ¹Ý ÁÖ½Ã
  • macular hemangioma
    ¹ÝÁ¡¼º Ç÷°üÁ¾
  • macular pigmentation
    ¹ÝÁ¡¼º Âø»ö
  • macular ring reflex
    Ȳ¹Ý·û ¹Ý»ç
  • perifollicular macular atrophy
    ¸ð³¶ ÁÖÀ§ ¹Ý»ó À§Ãà
  • senile macular degeneration
    ³ë³â Ȳ¹Ý º¯¼º
    µ¿ÀǾî=age-related macular degeneration. ³ë³â±â¿¡ È£¹ßµÇ°í ¹Ý¼ö¿¡¼­ ¾ç¾È¼ºÀÌ¸ç ¼ºº° Â÷ÀÌ´Â ¾ø´Ù. ¸ÕÀú µå·çÁ¨À̳ª ºê·çÅ©¸·ÀÇ º¯¼ºÀÌ ¼±ÇàÇϸç À̵éÀÌ »ö¼Ò »óÇÇ º¯¼º°ú »ö¼Ò »óÇÇ ¹Ú¸®¸¦ ÀÏÀ¸Å°°í ¸Æ¶ô¸·¿¡¼­ Ç÷°ü ½Å»ýÀÌ »ý°Ü °¨°¢ ½Å°æ ¸Á¸· ¹Ø¿¡ ÃâÇ÷ÀÌ ³ªÅ¸³­´Ù. ÀÌ·¯ÇÑ ÃâÇ÷ÀÌ ±âÁúÈ­µÇ¾î ¸Á¸· º¯¼ºÀ» ÀÏÀ¸Å°°Ô µÈ´Ù. Á᫐ ¾ÏÁ¡, ½Ã·Â Àå¾Ö, º¯½ÃÁõÀ» È£¼ÒÇÑ´Ù. ºê·çÅ©¸·ÀÇ º¯¼ºÀ̳ª ¸Á¸· »ö¼Ò ¹Ú¸®°¡ ÀÖÀ» ¶§ ±¤ÀÀ°í¸¦ Çϸé Ç÷°ü ½Å»ýÀÌ ÀÚ¶ó´Â °ÍÀ» ¸·À» ¼ö ÀÖ´Ù.
  • adiposogenital dystrophy
    Áö¹æ »ý½Ä±â ÀÌ¿µ¾çÁõ
    ºóÀÇ ½Å°æÇÐÀÚ Alfred Frohlich¿¡ ÀÇÇØ ÃÖÃÊ·Î ±âÀçµÈ °ÍÀ¸·Î ÇÁ·Ü¸®Èå ºñ¸¸Áõ ¶Ç´Â ½Ã»ó ÇϺμº ºñ¸¸ÁõÀ¸·Îµµ ºÒ¸°´Ù. ½Ã»ó ÇϺΠÁÖº¯ÀÇ Á¾¾ç Áõ»ó, °©Àڱ⠾ÇÈ­ÇÏ´Â ºñ¸¸, ¼º±â ¹ßÀ° ºÎÀüÀÌ 3ÁÖ Áõ»óÀ̰í Ç㸮, ÇϺ¹ºÎ, µÐºÎ µî¿¡ Áö¹æÀÌ Ä§ÂøÇÑ´Ù. »çÃá±â¿¡´Â 2Â÷ ¼ºÂ¡ÀÌ ¿ÀÁö ¾Ê°í ³²¼ºÀÇ °æ¿ì, ¿©¼º°ú °°Àº üÇüÀÌ µÈ´Ù. °ú·Î ½Ã¿¡´Â ½É½ÅÀÇ ÇǷΰ¡ µÎµå·¯Áø´Ù. JonsonÀº ƯÈ÷ ½Ã»ó ÇϺÎÀÇ Á¾¾ç, ±× ¹ÛÀÇ ¿øÀÎÀ¸·Î ÀÎÇÑ ±âÁú Àå¾Ö°¡ ÀÖ´Â »çÃá±â¹ßÁõÀÇ °ÍÀ» ÇÁ·Ü¸®Èå ÁõÈıºÀ̶ó Çϰí À̰ÍÀÌ ¾Æ´Ò ¶§¸¦ Áö¹æ¼º±â¼º ÀÌ¿µ¾çÁõÀ̶ó°í ¸»Çϰí ÀÖ´Ù.
  • adrenogenital dystrophy
    ºÎ½Å ¼º±â ¹ßÀ° ÀÌ»ó, ºÎ½Å ¼º±â ÀÌ¿µ¾çÁõ
  • central areolar choroidal dystrophy
    Á߽ɼº ¿øÇü ¸Æ¶ô¸· ÀÌ¿µ¾ç
  • central cloudy corneal dystrophy
    Á߽ɼº ȥŹ °¢¸· ÀÌ¿µ¾ç
  • distal muscular dystrophy
    ¿øÀ§ ±ÙÀÌ¿µ¾çÁõ
  • Duchenne pseudohypertrophic muscular dystrophy
    Duchenne À§ºñ´ë¼º ±ÙÀÌ¿µ¾çÁõ
  • dystrophy
    ¹ßÀ° ÀÌ»ó, ÀÌ¿µ¾çÁõ, ¿µ¾ç Àå¾Ö, ÀÌ¿µ¾ç, ¿µ¾ç½ÇÁ¶, ±â´ÉÀå¾Ö, À§ÃàÁõ
    ºÒ¿ÏÀüÇÑ ¿µ¾ç »óÅ·κÎÅÍ À¯¹ßµÇ´Â ±ÙÀ°ÀÇ ¹ßÀ°¼º º¯È­·Î¼­ ÁßÃ߽Űæ°è´Â Æ÷ÇÔÇÏÁö ¾ÊÀ¸¸ç, Áö¹æ º¯¼º, Å©±â´Â Áõ°¡ÇÏÁö¸¸ ÈûÀº °¨¼ÒÇÏ´Â »óŰ¡ Ư¡ÀÌ´Ù. ¿µ¾ç ºÎÁ· ¶Ç´Â ¿µ¾ç °áÇÌ¿¡ À¯·¡ÇÏ´Â ÀÏ¹Ý ÁúȯÀÇ. ƯÈ÷ ±Ù ÀÌ¿µ¾çÀ» ¶æÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
dominant inheritance dominance of traits
dominant lethal trait Trait, expressed in the phenotype if present in the genotype, that precludes having descendants. All such cases are necessarily sporadic and must represent new mutations as the usual methods of classical genetics provide no means of demonstrating any genetic component whatsoever, except for tenuous arguments such as advanced paternal age. Molecular biology may help although the methods may be tedious; if there is an epistatic gene that may mask the trait, the logic is more tractable, though complex.
(05 Mar 2000)
dominant oncogene <genetics, molecular biology, oncology> A gene that stimulates cell proliferation and can drastically increase the risk of cancer development when present in a single copy.
(09 Oct 1997)
dominant species <biology, ecology, zoology> For each stratum, dominant species are those that, when ranked in descending rank order and cumulatively totaled, immediately exceed 50 percent of the total dominance measure, plus any additional species comprising 20 percent or more of the total dominance measure for the stratum.
(09 Oct 1997)
dominant trait An outstanding mental or physical characteristic.
See: dominance of traits.
(05 Mar 2000)
kidney, polycystic, autosomal dominant A genetic disorder with autosomal dominant inheritance characterised by multiple cysts in both kidneys and progressive deterioration of renal function. It is usually caused by a mutant gene at the pkd1 locus on the short arm of chromosome 16, though mutations elsewhere in the genome can also cause the disease. The age of onset of symptoms varies widely.
(12 Dec 1998)
age-related macular degeneration A common macular degeneration beginning with drusen of the macula and pigment disruption and sometimes leading to severe loss of central vision.
(05 Mar 2000)
macular Maculate
1. Relating to or marked by macules.
2. Denoting the central retina, especially the macula retinae.
(05 Mar 2000)
macular amyloidosis A localised form of amyloidosis cutis characterised by pruritic symmetrical brown reticulated macules, especially on the upper back; microscopically, amyloid is deposited as small subepidermal globules.
(05 Mar 2000)
macular area An oval area of the sensory retina, 3 by 5 mm, temporal to the optic disk corresponding to the posterior pole of the eye; at its centre is the central fovea, which contains only retinal cones.
Synonym: area centralis, macula lutea, macular area, punctum luteum, Soemmerring's spot, yellow spot.
(05 Mar 2000)
macular arteries See: inferior macular arteriole, superior macular arteriole.
(05 Mar 2000)
macular atrophy Atrophoderma in which the skin becomes bag like and wrinkled.
Synonym: atrophia maculosa varioliformis cutis, atrophoderma maculatum, macular atrophy, primary idiopathic macular atrophy, primary macular atrophy of skin.
Origin: G. Anetos, relaxed, + derma, skin
(05 Mar 2000)
macular coloboma A defect of the central retina as a result of arrested development or intrauterine retinal inflammation.
(05 Mar 2000)
macular degeneration <ophthalmology> Breakdown or damage to a portion of the retina known as the macula.
Symptoms include blurring of vision (in central visual field), colours appear dim and difficulty reading or performing work up close.
(27 Sep 1997)
macular drusen Excrescences of Bruch's membrane that produce a window in the retinal pigment epithelium and are a feature of age-related macular retinal degeneration.
Synonym: macular drusen.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á